You can buy or sell Zogenix and other stocks, options, ETFs, and crypto commission-free!
Zogenix, Inc. Common Stock, also called Zogenix, is a pharmaceutical compan. Read More It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.
52 Week High
52 Week Low
Yahoo FinanceMay 13
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ZGNX, INVVY and S
NEW YORK, NY / ACCESSWIRE / May 13, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies.
Yahoo FinanceMay 9
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Zogenix, Inc. To Contact The Firm
Seeking AlphaMay 8
Zogenix, Inc. (ZGNX) CEO Stephen Farr on Q1 2019 Results - Earnings Call Transcript
Zogenix, Inc. (NASDAQ:ZGNX) Q1 2019 Results Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Brian Ritchie - LifeSci Advisors Stephen Farr - Chief Executive Officer Michael Smith - Chief Financial Officer Gail Farfel - Chief Development Officer Ashish Sagrolikar - Chief Commercial Officer Conference Call Participants Marc Goodman - SVB Leerink Jason Butler - GMP Securities Difei Yang - Mizuho Securities Yatin Suneja - Guggenheim Partners Operator Greetings, and welcome to th...
-$0.83 per share
-$0.83 per share